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ABSTRACT
This study investigates the effect of tobacco snuff on renal function using Wistar rat as a model. It involved adult 
rats (n=42) weighing 150-300g. They were assigned into a control group (A; n=6) and test groups B (n=12), C 
(n=12) and D (n=12). The groups were further divided into subgroups (1, 2, 3 and 4) representing durations of 2, 4, 
6 and 8 weeks respectively. The test groups were fed varying doses of tobacco snuff (tobacco plus potash). At the 
end of every 2 weeks, three randomly selected rats were prepared for blood sample collection into lithium heparin 
containers for laboratory analysis of creatinine, urea and uric acid. Results showed that creatinine levels of the test-
rats were higher than the control, but the recorded values were however, duration dependent. Interestingly, a similar 
but irregular pattern was observed for urea and uric acid levels. Over all, the significant increase (P<0.05) in renal 
function parameters of the test rats (as compared to the control values), suggests that the ingestion of tobacco snuff 
has harmful effects on kidney functions.
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_____________________________________________________________________
INTRODUCTION
In the world today, the use of smokeless tobacco is quite popular in the Far East, Middle East, and Europe (Bates et 
al., 2003), with a rising trend in the United States of America (USA) (Changrani and Gany, 2005). In Nigeria 
however, the powdered form called ‘tobacco snuff’, has potash added to it to serve as additive. It is either inhaled 
(sniffed) through the nose or applied orally (Ureme et al., 2007). According to Aduema et al. (2012), it comes in two 
different forms- ‘Tobacco snuff’ and ‘Chewing tobacco’.
Despite the awareness, that absorption of tobacco snuff is sometimes considered inefficient to provide an adequate 
nicotine substitute (Armitage et al., 1978; Turner et al., 1985), some have advocated its use as nicotine substitute for 
cigarette, since it is supposedly devoid of hazardous elements like tar and carbon monoxide (Russel et al., 1980). 
Unfortunately, chronic absorption of nicotine from smokeless tobacco results in nicotine addiction (Hatsukami et al., 
2004; Hatsukami and Severson, 1999 and PHS, 1998).
Of greater concern however, is the fact that several scientific studies have reported that the phytochemical 
constituents of tobacco snuff is carcinogenic (IARC, 1985; Hecht et al., 1986; PHS, 1986; Brunnemann and 
Hoffmann, 1992; NCI, 1992; Hoffmann and Djordjevic, 1997 and IARC, 2007). According to Jorenby et al. (1998), 
the precise health effects of smokeless tobacco are uncertain but are not necessarily limited to oral cancers. 
Generally, smokeless tobacco has been associated with periodontal disease (Ernster et al., 1990; Fisher et al., 2005), 
precancerous oral lesions (Mattson and Winn, 1989), oral cancer (Stockwell 1986), and cancer of the kidney 
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(Goodman et al., 1986; Muscat et al., 1995), as well as pancreas (Muscat et al., 1997), and digestive system
pathogenesis (Henley et al., 2005).
In addition, the involvement of its highly reactive radicals in carcinogenesis, DNA damage, alteration of cellular 
antioxidant defense system and reduction in kidney glutathione (GSH), Superoxide dismutase (SOD), catalase 
(CAT), and glutathione peroxidase (GPx), as well as the induction of lipid peroxidation in kidney (Pramod et al.,
2005), raises a lot of public health concern. 
With focus on the rising trend in tobacco snuff addition therefore, this study investigates the effect of oral tobacco 
snuff consumption on renal function in adult Wistar rats.
MATERIALS AND METHODS
Experimental Animals: Forty two adult Wistar rats of comparable sizes and weighing (150-300g) were purchased 
from the animal farm of Anthonio Research Center, Ekpoma, Edo state, Nigeria. They were transferred to the 
experimental site where they were allowed two weeks of acclimatization in a wooden wire mesh cages under 
standard laboratory procedure.
Substance of study: Dry leaves of tobacco and potash were purchased from Ogbete main market, Enugu state, 
Nigeria. The tobacco leaves were authenticated by a botanist in the Department of Botany, Ambrose Alli University, 
Ekpoma, Edo state, Nigeria.
Substance preparation: The tobacco leaves and potash were blended into powder using a mortar and iron pestle 
and then stored prior to the study. The blended tobacco leaves with potash were weighed using an electronic balance 
(Denver Company, USA, 200398. IREV. CXP-3000) to obtain the various required doses. For the purpose of this 
study, feed pellets were prepared as described by Nwaopara et al., (2011).
Animal grouping: The experiment involved four stages: stage 1, which lasted for a period of 2 weeks; stage 2,
which lasted for a period of 4 weeks; stage 3, which lasted for a period of 6 weeks; and stage 4, which lasted for a 
period of 8 weeks. The rats were divided into four groups (A, B, C and D) with group A serving as control, while 
groups B, C and D served as the test groups. The test groups were further divided into four groups (B1, C1, D1; B2, 
C2, D2; B3, C3, D3; and B4, C4, D4) representing four experimental phases/duration (2, 4, 6 and 8 weeks) and 
varying doses of tobacco dust mixed with potash respectively. At the end of 2, 4, 6 and 8 weeks respectively, 3 
randomly selected rats from the groups were prepared for blood sample collection via cardiac puncture.
Study duration: The preliminary studies, animal acclimatization, substance procurement (tobacco leaves and 
potash), actual animal experiment and evaluation of results, lasted from September, 2012 to February, 2013. 
However, the actual administration of oral tobacco dust and potash to the test animals lasted for 8 weeks (2weeks, 
4weeks, 6weeks and 8 weeks respectively).
Substance administration: In phase 1 (2 weeks), group A (control) received 100g of feed and distilled water only 
whereas test group B, C and D received 97.12g of feed, 2.4g of tobacco dust and 0.48g of potash; 94.24g of feed, 
4.80g of tobacco dust and 0.96g of potash; and 91.36g of feed, 7.20g of tobacco dust and 1.44g of potash 
respectively. Each test group received distilled water ad libitum.
In phase 2 (4 weeks), group A (control) received 75g of feed and distilled water only, whereas test group B, C and D 
received 72.84g of feed, 1.8g of tobacco dust and 0.36g potash; 70.68g of feed, 3.6g of tobacco dust and 0.72g of 
potash; and 68.52g of feed, 5.4g of tobacco dust and 1.08g of potash respectively. Each test group received distilled 
water ad libitum.
In phase 3 (6 weeks), group A (control) received 50g of feed and distilled water only, whereas test group B3, C3 and 
D3 received 48.56g of feed, 1.2g of tobacco dust and 0.24g potash; 47.12g of feed, 2.4g of tobacco dust and 0.48g 
of potash; and 45.68g of feed, 3.6g of tobacco dust and 0.72g of potash respectively. Each test group received 
distilled water ad libitum.
In phase 4 (8 weeks), group A (control) received 25g of feed and distilled water only, whereas test group B4, C4 and 
D4 received 24.28g of feed, 0.6g of tobacco dust and 0.12g potash; 23.56g of feed, 1.2g of tobacco dust and 0.24g 
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of potash; and 22.84g of feed, 1.8g of tobacco dust and 0.36g of potash respectively. Each test group received 
distilled water ad libitum.
The concentrations of tobacco used in this study were deduced from the work of Bagchi et al. (1994) while that of 
potash was deduced from Ugbor et al. (2013).
Sample collection and sample analysis: At the end of each stage of the experiment, blood samples were collected 
from the rats via cardiac puncture into a lithium heparin primed container. This was followed by centrifugation to 
obtain plasma samples which were then stored at -70o C prior to laboratory analysis.
Plasma creatinine, urea, and uric acid, were estimated by Jaffe’s method (Fabiny and Ertingshauen, 1971), Urease-
Berthelots colorimetric method (Sims, 2006) and enzymatic (uricase) colorimetric method (Fossati et al., 1980) 
respectively.
Data analysis: All the data collected were subjected to statistical analysis using SPSS (version 18). The test groups’ 
values were compared with the control using student’s t-test and ANOVA (LSD) at 95% level of confidence.
RESULTS
Table 1 below represents the effect of tobacco snuff consumption on creatinine levels of the experimental animals 
and control. Creatinine levels in the tests showed no statistical difference (P>0.05) from the values of the control 
(0.76±0.12mg/dl) in the first 2 weeks, 6 weeks and 8 weeks treatment periods. However, for the 4-week period, 
there was a statistically significant increase (P< 0.05) in creatinine values in group C (1.40±0.32mg/dl) and D 
(1.31±0.34mg/dl) as compared with the control.
For urea, the results in table 2 showed that at the end of 2 weeks, there was no statistical difference (P>0.05) in the 
test groups when compared to control values (47.28±7.15mg/dl). In the 4-week ingestion period, it was observed 
that except for group C (115.08±96.60mg/dl), which showed a statistical increase in urea level, group B and D urea 
levels did not differ statistically from the control. In comparison with the control also, a statistically significant 
difference (P<0.05) was observed in group B (63.13±8.91mg/dl) and D (65.63±4.71mg/dl) at the end of 6 weeks, but 
only in group D (65.15±4.74mg/dl) at the end of 8 weeks.
























































N/B: all the values of the test groups with different subscript from the controls are significantly different at p<0.05.
In table 3, uric acid showed no statistical difference in test group values when compared with the control values 
(7.13±0.47mg/dl) at the end of 2 weeks. But at the end of 4 weeks, a statistically significant increase was observed 
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in Group B (11.34±0.16mg/dl) and D (11.26±2.25mg/dl), while at the end of 6 weeks, only group B 
(12.11±1.22mg/dl) presented a statistically significant increase when compared with the control. In addition, group 
B (10.24±3.19mg/dl), C (13.40±1.97mg/dl) and D (10.71±0.45mg/dl) presented a significant increase in uric acid 
levels when compared to the control value, at the end of 8 weeks ingestion period.
In view of the observed changes in the parameters for assessing renal function herein investigated, our results did 
show that tobacco snuff consumption had an impact on renal function, and the observed changes were duration and 
dosage dependent.




























N/B: all the values of the test groups with different subscript from the controls are significantly different at p<0.05.
DISCUSSION
The observed alterations in renal function parameters are in line with the reports by Pramod et al., (2006) and 
Gonzalez (1999), who stated that aqueous extract of smokeless tobacco, impairs enzymatic antioxidant defense 
system and induces oxidative stress/lipid peroxidation in liver, lung, and kidney. Already, this oxidative stress–
induced lipid peroxidation, according to Gonzalez (1999) and Pramod et al. (2006), has been implicated in 
malignant transformation. However, our findings disagrees with the reports by Raj Shrestha et al. (2012), that Pan 
masala (a brand of smokeless tobacco) induces significant elevated levels of ALT and AST amongst consumers, but 
not serum creatinine, urea and uric acid.
Although high ratios of creatinine and urea is said to be a factor of either post-renal obstruction or pre-renal uremia 
superimposed on renal disease (Fossati et al., 1994; Thoene, 1999; Newman and Price, 1998), it is known however, 
that elevated creatinine level is associated with abnormal renal function, especially glomerular function (Bishop et 
al., 2005; Usunobun et al., 2012). Interestingly, creatinine -being a definitive marker for kidney function, was 
observed to increase statistically in the 4th week of this study, but remained high thereafter; though not significant. 
Thus, mild and lethal doses of tobacco snuff may be renotoxic based on the results of this study.
As regards urea being an indicator for kidney disorder, the elevated values in the test groups, suggests that tobacco 
snuff may contain some toxic components that are nephrotoxic which, according to Varely et al. (1987), can be 
linked with the fact that the presence of toxic compounds increases blood urea and decreases plasma protein. The 
observed increase in uric acid amongst the test groups further points to the renotoxic potential of tobacco snuff. 
Moreover, there is evidence that an increase in renal retention of uric acid can occur in cases of acute or chronic 
renal disease/ failure (Newman and Price, 1998).
Nevertheless, the mechanism by which tobacco snuff induces renal damage may be through enhancing the synthesis 
of free radicals which, according to Danko and Chaschin (2005) and Usunobun et al. (2012), leads to lipid and 
protein peroxidation, DNA damage and carcinogenesis. These may affect glomerular function leading to elevated 
serum markers of renal function. Molander et al., (2000) and Ross, (2006) had earlier stated that a progressive 
kidney failure can be associated with a gradual decrease of renal and non-renal elimination of nicotine, and this 
potentiates nephrotoxicity. Also, the effects of heavy metals in tobacco and heavy metals like Cadmium (Cd), 
Mercury (Hg) and Lead (Pb), might be another possible mechanism for tobacco-induced renal damage (Addo et al., 
2008; Roszczenko et al., 2004; Satarug and Moore, 2004; Ross, 2006).
On the other hand, the observations of this study, may not be unrelated to the carcinogenic potentials of tobacco 
snuff as it has been previously reported that smokeless tobacco contains 4-(methylnitrosamino)-1-(3-pyridyl)-1-
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butane (NNK) and N′-nitrosonornicotine (NNN) (Boffetta et al., 2008), which are known carcinogenic agents, and 
without doubt, have capacity to induce the elevation of markers and subsequently, kidney damage. 
Judging by the findings of this study therefore, it is obvious that an excessive consumption of tobacco snuff may be 
toxic, which, in the case of the kidney, can alter renal function. As such, there is a need to draw the attention of 
consumers to the hazardous effects and subsequent health implications of excessive tobacco snuff consumption. 
Also, beyond the slogan by the Nigerian Federal Ministry of Health that “tobacco smoking is dangerous to health,
and that smokers are liable to die young”, there is still an urgent need for more proactive measures as “a stitch in 
time, saves nine. 
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